Reports >
Life Sciences
>
Stent Grafts Market Report
Stent Grafts Market Report
First published: 12 October 2024 | Last updated: 28 May 2026 | Report Code: stent-grafts
Stent Grafts Market — USD 3.5 billion in 2023, Growing to USD 6.48B by 2033 at 6.2% CAGR
This report provides a comprehensive analysis of the global Stent Grafts market, including current trends, market size, forecast growth rates, and segmentation from 2023 to 2033. It examines regional dynamics, technological advancements, and key players in the industry.
Key Takeaways
- Global market expands from $3.50 Billion in 2023 to $6.48 Billion in 2033 with a 6.2% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe rises from $0.84 Billion in 2023 to $1.56 Billion in 2033; Asia Pacific grows from $0.74 Billion to $1.37 Billion.
- Product innovation, minimally invasive procedures, and material advances are principal drivers supporting adoption and spending.
- Key manufacturers include Medtronic, Boston Scientific, Abbott Laboratories, Cook Medical, and Johnson & Johnson.
Stent Grafts Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines the Stent Grafts market performance and outlook between 2023 and 2033. The market is projected to grow from $3.50 Billion in 2023 to $6.48 Billion in 2033 at a 6.2% CAGR. Demand is supported by rising prevalence of vascular conditions, expansion of minimally invasive endovascular techniques, and improvements in device materials and designs. Regional patterns show North America as the largest market, while Europe, Asia Pacific, Latin America and Middle East & Africa also register steady expansion. The study evaluates segmentation by design, product type, material and end user, and profiles major suppliers such as Medtronic, Boston Scientific, Abbott Laboratories, Cook Medical and Johnson & Johnson. Findings draw on primary interviews, company disclosures and secondary publications, with emphasis on technology-driven adoption and the impact of clinical and regulatory developments on market access.
Key Growth Drivers
- Increasing incidence of vascular diseases and aging populations driving higher procedure volumes.
- Shift toward minimally invasive endovascular surgeries that favor stent graft adoption over open procedures.
- Material and design improvements, including bioresorbable and advanced alloys, enhancing device performance.
- Ongoing R&D and collaboration between manufacturers and healthcare providers accelerating product availability.
- Regulatory pathways and clinical evidence facilitating wider adoption and reimbursement in multiple regions.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.50 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $6.48 Billion |
| Top Companies | Medtronic , Boston Scientific, Abbott Laboratories, Cook Medical, Johnson & Johnson |
| Published Date | 12 October 2024 |
| Last Modified Date | 28 May 2026 |
Stent Grafts Market Overview
Customize Stent Grafts Market Report market research report
- ✔ Get in-depth analysis of Stent Grafts market size, growth, and forecasts.
- ✔ Understand Stent Grafts's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Stent Grafts
What is the Market Size & CAGR of Stent Grafts Market Report market in 2023?
Stent Grafts Industry Analysis
Stent Grafts Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Stent Grafts Market Report Market Analysis Report by Region
Europe Stent Grafts Market Report:
Europe grows from $0.84 Billion in 2023 to $1.56 Billion in 2033. Expansion is supported by increasing use of minimally invasive procedures, investments in vascular care, and ongoing clinical adoption of improved device materials and designs across hospitals and specialized centers.Asia Pacific Stent Grafts Market Report:
Asia Pacific grows from $0.74 Billion in 2023 to $1.37 Billion in 2033. Growth reflects rising incidence of cardiovascular conditions, expanding healthcare capacity, and growing uptake of advanced interventional procedures and technologies in regional medical centers.North America Stent Grafts Market Report:
North America is largest regional market, rising from $1.2 Billion in 2023 to $2.23 Billion in 2033. Regional growth is supported by advanced healthcare infrastructure, strong adoption of endovascular techniques, and established reimbursement pathways that facilitate access to innovative stent graft technologies.South America Stent Grafts Market Report:
Latin America grows from $0.23 Billion in 2023 to $0.43 Billion in 2033. Market momentum is influenced by improving access to specialized vascular care, gradual adoption of minimally invasive interventions, and incremental investment in device availability and training.Middle East & Africa Stent Grafts Market Report:
Middle East and Africa grows from $0.48 Billion in 2023 to $0.9 Billion in 2033. Drivers include increased healthcare investments, expanding procedural capabilities, and a growing focus on minimally invasive treatments that favor stent graft deployment.Tell us your focus area and get a customized research report.
Research Methodology
Stent Grafts Market Analysis By Product Type
The Stent-Grafts market is predominantly comprised of self-expanding stent grafts, which hold an 86.34% market share, valued at 3.02 billion USD in 2023 and projected to grow to 5.60 billion USD by 2033, indicating robust demand. Balloon-expandable stent grafts are also notable, although they represent a smaller share at 13.66% of the market, growing from 0.48 billion USD to 0.89 billion USD during the forecast period.
Stent Grafts Market Analysis By Design
The design of stent grafts significantly impacts their performance. Self-expanding designs are optimal for many applications due to ease of use and adaptability in complex anatomies. This segment's robust growth is directly linked to their increased use in peripheral interventions.
Stent Grafts Market Analysis By End User
Hospitals represent the largest end-user segment for stent grafts, holding an 86.34% market share, with sizes growing from 3.02 billion USD in 2023 to 5.60 billion USD by 2033. Ambulatory surgical centers are emerging as an important segment, reflecting a shift towards outpatient procedures, yet they still account for a smaller share at 13.66%.
Stent Grafts Market Analysis By Material
Metal alloys are predominantly utilized in stent graft construction, accounting for an 86.34% share of the market. The superior durability and strength of these materials contribute to their prevalent use in vascular interventions. Bioresorbable polymers, while representing a smaller segment, are gaining traction due to their potential for improved patient outcomes.
Stent Grafts Market Analysis By Surgery Type
Open surgery remains the dominant procedure type for stent graft placement, capturing an 86.34% market share. However, endovascular surgeries are witnessing a rise as less invasive techniques become more popular, gaining acceptance due to faster recovery times and fewer complications.
Stent Grafts Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Stent Grafts Industry
Medtronic :
A global leader in medical technology, Medtronic specializes in developing innovative stent graft systems that enhance patient outcomes and address complex vascular conditions.Boston Scientific:
Known for its pioneering contributions to the medical devices industry, Boston Scientific focuses on developing advanced stent graft technologies for various vascular applications.Abbott Laboratories:
Abbott is a prominent healthcare company that produces state-of-the-art stent grafts designed for optimal performance and patient safety.Cook Medical:
Cook Medical is a leading manufacturer specializing in vascular interventions, offering a range of stent graft products tailored to diverse patient needs.Johnson & Johnson:
A major player in the medical device industry, Johnson & Johnson produces high-quality stent grafts renowned for their reliability and effectiveness in patient care.We're grateful to work with incredible clients.
FAQs
What is the market size of the Stent Grafts market in 2023?
The market size in 2023 is $3.50 Billion according to the report's base-year estimate.
How big will the Stent Grafts market be in 2033?
The market is projected to reach $6.48 Billion by 2033 based on the provided forecast.
What is CAGR for the 2023 to 2033 period?
The compound annual growth rate for 2023 to 2033 is 6.2% as stated in the report data.
Is there a single fastest Growing region in the Stent Grafts Market Report market?
No single fastest-growing region is stated for the Stent Grafts Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as key players?
Top companies named include Medtronic, Boston Scientific, Abbott Laboratories, Cook Medical, and Johnson & Johnson.
What are principal trends shaping the market?
Primary trends include minimally invasive procedures, advanced materials such as bioresorbable options, and technology-led device enhancements.
How is the market segmented in the report?
Segmentation covers design, product type, material, surgery type and end user, with detailed sub-segment listings for each category.
What research methods were used for the report?
The methodology includes primary interviews with industry experts, secondary research of company reports and publications, and data triangulation with internal validation.